Fibrodysplasia ossificans progressiva: Clinical course, genetic mutations and genotype-phenotype correlation

Molecular Syndromology

Volumn 5, Issue 5, 2014, Pages 201-211

  Hüning, Irina ^a   Gillessen Kaesbach, Gabriele ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

ACVR1; FOP; Great toe malformations; Heterotopic ossifications; Progressive immobility

Indexed keywords

DISEASE COURSE; EXON; FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; GENE MUTATION; GENETICS; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MEDICAL LITERATURE; OSSIFYING MYOSITIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

EID: 84906883828     PISSN: 16618769     EISSN: 16618777     Source Type: Journal    
DOI: 10.1159/000365770     Document Type: Review

References (42)

1. Al-Haggar M, Ahmad N, Yahia S, Shams A, Hasa-neen B, et al: Sporadic fibrodysplasia ossifi-cans progressiva in an Egyptian infant with c.617GA mutation in ACVR1 gene: a case report and review of literature. Case Rep Genet 2013: 834605 (2013).
2. Bauer KH, Bode W: Erbpathologie der Stützgewebe beim Menschen. Erbbiologie und Erbpatholo-gie körperlicher Zustände und Funktionen, vol 1, p 105 (1940).
3. Bocciardi R, Bordo D, Di Duca M, Di Rocco M, Ravazzolo R: Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancements. Eur J Hum Genet 17: 311-318 (2009).
4. Carvalho DR, Navarro MM, Martins BJ, Coelho KE, Mello WD, et al: Mutational screening of ACVR1 gene in Brazilian fibrodysplasia ossi-ficans progressiva patients. Clin Genet 77: 171-176 (2010).
5. Chen D, Zhao M, Mundy GR: Bone morphoge-netic proteins. Growth Factors 22: 233-241 (2004).
6. Cohen RB, Hahn GV, Tabas JA, Peeper J, Levitz CL, et al: The natural history of heterotopic ossification in patients who have fibrodyspla-sia ossificans progressiva: a study of forty-four patients. J Bone Joint Surg Am 75: 215-219 (1993).
7. Connor JM, Evans DA: Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients. J Bone Joint Surg Br 64: 76-83 (1982).
8. Deirmengian GK, Hebela NM, O'Connell M, Gla-ser DL, Shore EM, Kaplan FS: Proximal tibial osteochondromas in patients with fibrodys-plasia ossificans progressiva. J Bone Joint Surg Am 90: 366-374 (2008).
9. Furuya H, Ikezoe K, Wang L, Ohyagi Y, Moto-mura K, et al: A unique case of fibrodysplasia ossificans progressiva with an ACVR1 mutation, G356D, other than the common mutation (R206H). Am J Med Genet A 146A:459-463 (2008).
10. Gazzerro E, Canalis E: Bone morphogenetic proteins and their antagonists. Rev Endocr Metab Disord 7: 51-65 (2006).
11. Gregson CL, Hollingworth P, Williams M, Petrie KA, Bullock AN, et al: A novel ACVR1 mutation in the glycine/serine-rich domain found in the most benign case of a fibrodysplasia os-sificans progressiva variant reported to date. Bone 48: 654-658 (2011).
12. Groppe JC, Shore EM, Kaplan FS: Functional modeling of the ACVR1 (R206H) mutation in FOP. Clin Orthop Relat Res 462: 87-92 (2007).
13. Hammond P, Suttie M, Hennekam RC, Allanson J, Shore EM, Kaplan FS: The face signature of fibrodysplasia ossificans progressiva. Am J Med Genet A 158A:1368-1380 (2012).
14. Kaplan FS, Glaser DL: Thoracic insufficiency syndrome in patients with fibrodysplasia ossifi-cans progressiva. Clin Rev Bone Miner Metab 3: 213-216 (2005).
15. Kaplan FS, Strear CM, Zasloff MA: Radiographic and scintigraphic features of modeling and remodeling in the heterotopic skeleton of patients who have fibrodysplasia ossificans pro-gressiva. Clin Orthop Relat Res 238-247 (1994)
16. Kaplan FS, Glaser DL, Pignolo RL, Shore EM: Introduction. Clin Rev Bone Miner Metab 3: 175-177 (2005a).
17. Kaplan FS, Shore EM, Gupta R, Billings PC, Gla-ser DL, et al: Immunological features of fibro-dysplasia ossificans progressiva and the dys-regulated BMP4 Pathway. Clin Rev Bone Miner Metab 3: 189-193 (2005b).
18. Kaplan FS, Groppe J, Pignolo RJ, Shore EM: Mor-phogen receptor genes and metamorpho-genes: skeleton keys to metamorphosis. Ann NY Acad Sci 1116: 113-133 (2007).
19. Kaplan FS, Xu M, Seemann P, Connor JM, Glaser DL, et al: Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphoge-netic protein (BMP) type I receptor ACVR1. Hum Mutat 30: 379-390 (2009).
20. Levy CE, Lash AT, Janoff HB, Kaplan FS: Conductive hearing loss in individuals with fibro-dysplasia ossificans progressiva. Am J Audiol 8: 29-33 (1999).
21. Massagué J, Seoane J, Wotton D: Smad transcription factors. Genes Dev 19: 2783-2810 (2005).
22. McKusick VA: Hereditable disorders of connective tissue. J Chronic Dis 3: 521-556 (1956).
23. Morales-Piga A, Bachiller-Corral J, Trujillo-Tie-bas MJ, Villaverde-Hueso A, Gamir-Gamir ML, et al: Fibrodysplasia ossificans progres-siva in Spain: epidemiological, clinical, and genetic aspects. Bone 51: 748-755 (2012).
24. Nakahara Y, Katagiri T, Ogata N, Haga N: ACVR1 (587TC) mutation in a variant form of fibro-dysplasia ossificans progressiva: second report. Am J Med Genet A 164A:220-224 (2014).
25. Nakajima M, Haga N, Takikawa K, Manabe N, Nishimura G, Ikegawa S: The ACVR1 617GA mutation is also recurrent in three Japanese patients with fibrodysplasia ossificans pro-gressiva. J Hum Genet 52: 473-475 (2007).
26. Peltier LF: A case of extraordinary exostoses on the back of a boy. 1740. John Freke (1688-1756). Clin Orthop Relat Res 346: 5-6 (1998).
27. Petrie KA, Lee WH, Bullock AN, Pointon JJ, Smith R, et al: Novel mutations in ACVR1 result in atypical features in two fibrodysplasia ossificans progressiva patients. PLoS One 4:e5005 (2009).
28. Pignolo RJ, Suda RK, Kaplan FS: The fibrodyspla-sia ossificans progressive lesion. Clin Rev Bone Miner Metabol 3: 195-200 (2005).
29. Pignolo RJ, Shore EM, Kaplan FS: Fibrodysplasia ossificans progressiva: clinical and genetic aspects. Orphanet J Rare Dis 6: 80 (2011).
30. Ratbi I, Borcciadi R, Regragui A, Ravazzolo R, Se-fiani A: Rarely occurring mutation of ACVR1 gene in Moroccan patient with fibrodysplasia ossificans progressiva. Clin Rheumatol 29: 119-121 (2010).
31. Schaffer AA, Kaplan FS, Tracy MR, O'Brien ML, Dormans JP, et al: Developmental anomalies of the cervical spine in patients with fibrodys-plasia ossificans progressiva are distinctly different from those in patients with Klippel-Feil syndrome: clues from the BMP signaling pathway. Spine 30: 1379-1385 (2005).
32. Shen Q, Little SC, Xu M, Haupt J, Ast C, et al: The fibrodysplasia ossificans progressive R206H ACVR1 mutation activates BMP independent chondrogenesis and zebrafish embargo ven-tralization. J Clin Invest 119: 3462-3472 (2009).
33. Shi Y, Massagué J: Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 13; 113:685-700 (2003).
34. Shore EM, Feldman GJ, Xu M, Kaplan FS: The genetics of fibrodysplasia ossificans progres-siva. Clin Rev Bone Miner Metab 3: 201-204 (2005).
35. Shore EM, Xu M, Feldman GJ, Fenstermacher DA, Cho TJ, et al: A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans pro-gressiva. Nat Genet 38: 525-527 (2006).
36. Smith R, Russell RG, Woods CG: Myositis ossifi-cans progressiva. Clinical features of eight patients and their response to treatment. J Bone Joint Surg Br 58: 48-57 (1976).
37. Stefanova I, Grünberg C, Gillessen-Kaesbach G: Fibrodysplasia ossificans progressiva. Med Genet 24: 20-32 (2012).
38. Urist MR: Bone: formation by autoinduction. Science 150: 893-899 (1965).
39. Virdi AS, Shore EM, Oreffo RO, Li M, Connor JM, et al: Phenotypic and molecular heterogeneity in fibrodysplasia ossificans progressiva. Calcif Tissue Int 65: 250-255 (1999).
40. Wagner TU: Bone morphogenetic protein signaling in stem cells-one signal, many consequences. FEBS J 274: 2968-2976 (2007).
41. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, et al: Novel regulators of bone formation: molecular clones and activities. Science 242: 1528-1534 (1988).
42. Zhang W, Zhang K, Song L, Pang J, Ma H, et al: The phenotype and genotype of fibrodyspla-sia ossificans progressiva in China: a report of 72 cases. Bone 57: 386-391 (2013).